amifostine anhydrous has been researched along with alprostadil in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (66.67) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
Collins, PW; Hanson, WR; Houseman, KA; Nelson, AK | 1 |
Collins, PW; Hanson, WR; Houseman, KA | 1 |
1 review(s) available for amifostine anhydrous and alprostadil
Article | Year |
---|---|
Radiation protection in vivo by prostaglandins and related compounds of the arachidonic acid cascade.
Topics: Alprostadil; Amifostine; Animals; Arachidonic Acids; Misoprostol; Prostaglandins; Radiation Injuries, Experimental; Radiation-Protective Agents | 1988 |
2 other study(ies) available for amifostine anhydrous and alprostadil
Article | Year |
---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Radiation protection of the murine intestine by misoprostol, a prostaglandin E1 analogue, given alone or with WR-2721, is stereospecific.
Topics: Alprostadil; Amifostine; Animals; Intestines; Male; Mice; Misoprostol; Organothiophosphorus Compounds; Stereoisomerism | 1988 |